Tyndall Mark Anthony (CIK 1944622) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Buy NONE (6,576 shares), Sell NONE (2,107 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Keenova Therapeutics plc (NONE) | EVP & CLO and Corp Sec | Buy | 6,576 | $0 |
| 2026-01-05 | Keenova Therapeutics plc (NONE) | EVP & CLO and Corp Sec | Sell | 2,107 | $0 |
Source: SEC Form 4 filings · as of 2026-01-05